We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

YOU:NYSEClear Secure, Inc. Analysis

Data as of 2026-09-19 - not real-time

$38.10

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind Clear Secure, Inc. is neutral at $38.10, with no clear ordering between short and long averages. It has lost 28.1% over the past 30 days. Momentum indicators put RSI at 22.1 (oversold) with MACD reading bearish. Watch $37.88 as support and $45.77 as the nearer resistance level.
Multiples put this in fair territory: 25.7 times earnings against the sector's 33.6. The average analyst target implies 56.6% above today's level. Revenue is growing at 26.6% on a 14.8% profit margin. The 1.51% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 33.9%, a beta of 0.69 and a maximum drawdown of 38.9%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 5/10 long-term conviction.

Top Market Events

This article first appeared on GuruFocus.NEW YORK, Aug. 5, 2026 /PRNewswire/ -- Clear Secure, Inc. NYSE: YOU , the secure identity company, has released...4dClear Secure Chief Accounting Officer Sells 6,059 SharesDennis Liu sold shares to satisfy tax withholding and a...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • RSI at 22.1 signals oversold conditions
  • Trading below the 200-day average of 46.64
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • RSI at 22.1 signals oversold conditions
  • P/E of 25.7 versus sector average of 33.6
  • Trading below the 200-day average of 46.64

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • P/E of 25.7 versus sector average of 33.6
  • Analyst targets imply +56.6% versus the current price
  • Revenue growth of +26.6%

Key Metrics & Analysis

Financial Health

Revenue Growth26.60%
Profit Margin14.78%
P/E Ratio25.7
ROE119.17%
ROA11.40%
Debt/Equity45.14
P/B Ratio21.1
Op. Cash Flow$542.6M
Free Cash Flow$418.4M
Industry P/E33.6

Technical Analysis

TrendNeutral
RSI22.1
Support$37.88
Resistance$45.77
MA 20$42.93
MA 50$48.34
MA 200$46.64
MACDBearish
VolumeIncreasing
Fear & Greed Index94.98

Valuation

Fair Value$109.94
Target Price$59.67
Upside/Downside56.61%
GradeFair
TypeGrowth
Dividend Yield1.51%

Risk Assessment

Beta0.69
Volatility33.88%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.